Alcon Inc. (BVMF:A2LC34)
Brazil · Delayed Price · Currency is BRL | Market Cap | 176.30B -23.1% |
| Revenue (ttm) | 55.47B +7.1% |
| Net Income | 4.27B -26.9% |
| EPS | 8.70 -25.9% |
| Shares Out | n/a |
| PE Ratio | 41.26 |
| Forward PE | 18.91 |
| Dividend | 0.11 (0.31%) |
| Ex-Dividend Date | May 5, 2026 |
| Volume | 3 |
| Open | 35.52 |
| Previous Close | n/a |
| Day's Range | 35.52 - 35.52 |
| 52-Week Range | 30.88 - 47.90 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 11, 2026 |
About Alcon
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company’s cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS... [Read more]
Financial Performance
In 2025, Alcon's revenue was $10.40 billion, an increase of 4.94% compared to the previous year's $9.91 billion. Earnings were $980.00 million, a decrease of -3.73%.
Financial numbers in USD Financial StatementsNews
Alcon (ALC) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Alcon (ALC), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarte...
Alcon (ALC) Unveils Advanced Training Center for Vitreoretinal Surgery
Alcon (ALC) Unveils Advanced Training Center for Vitreoretinal Surgery
Alcon opens second center with Aravind Eye Care System
Aravind Eye Care System and Alcon (ALC) announced the launch of the Aravind Alcon Global Centre of Excellence for Vitreoretinal Surgery Training in Coimbatore. Building on the launch of the…
A Look at Alcon Inc (ALC) After 3.8% Decline -- GF Value $91.41 vs Price $67.35
A Look at Alcon Inc (ALC) After 3.8% Decline -- GF Value $91.41 vs Price $67.35
Alcon price target lowered to $80 from $85 at Mizuho
Mizuho lowered the firm’s price target on Alcon (ALC) to $80 from $85 and keeps an Outperform rating on the shares. The firm adjusted targets in the medical device and…
Alcon Inc (ALC) Shares Fall 3.1% -- What GF Score of 71 Tells Investors
Alcon Inc (ALC) Shares Fall 3.1% -- What GF Score of 71 Tells Investors
RxSight Q2 Sales Sink 20% as Alcon Deal Bolsters 2026 Outlook
RxSight NASDAQ: RXST reported preliminary second-quarter financial results and provided updates on its product pipeline following a newly announced strategic collaboration agreement with Alcon, with m...
RxSight Updates FY2026 Revenue Outlook After Alcon Deal; Cuts Product Sales Forecast; Stock Down
(RTTNews) - RxSight, Inc. (RXST), a commercial-stage ophthalmic medical device company, announced preliminary financial results for the second quarter of 2026 and updated the full-year 2026 guidance f...
Alcon Inks Partnership With RxSight To Develop Adjustable PICOLs For Deal Value Up To $200 Mln
(RTTNews) - Alcon Inc. (ALC), an eye care company specializing in surgical and vision care products, on Monday announced that it has entered into a non-exclusive collaboration with RxSight, Inc. (RXST...
Mexican Gold Mining Corp.: Alcon Silver Announces Shareholder Approval of Arrangement
Vancouver, British Columbia--(Newsfile Corp. - July 6, 2026) - Alcon Silver Corp. ("Alcon") and Mexican Gold Mining Corp. (TSXV: MEX) ("Mexican Gold") announce that, in connection with the previou...
Alcon Silver Announces Shareholder Approval of Arrangement
Vancouver, British Columbia--(Newsfile Corp. - July 6, 2026) - Alcon Silver Corp. ("Alcon") and Mexican Gold Mining Corp. (TSXV: MEX) ("Mexican Gold") announce that, in connection with the previously ...
Alcon (ALC) Partners with RxSight for Innovative Lens Development
Alcon (ALC) Partners with RxSight for Innovative Lens Development
Alcon, RxSight enter non-exclusive pact to develop adjustable PCIOLs
Alcon (ALC) and RxSight (RXST) announced a non-exclusive collaboration to jointly develop adjustable presbyopia-correcting intraocular lenses, or PCIOLs. Under the collaboration, the companies will be...
Alcon, RxSight announce collaboration to develop adjustable PCIOLs
The firm states: “Alcon (ALC) and RxSight (RXST) announced a non-exclusive collaboration to jointly develop adjustable presbyopia-correcting intraocular lenses, or PCIOLs. Under the collaboration, the...
Alcon Inc (ALC) Stock Up 4.2% and Still Undervalued -- GF Score: 71/100
Alcon Inc (ALC) Stock Up 4.2% and Still Undervalued -- GF Score: 71/100
Alcon price target lowered to $85 from $90 at Argus
Argus lowered the firm’s price target on Alcon (ALC) to $85 from $90 and keeps a Buy rating on the shares. Shares trade roughly 35% below all-time highs and at…
Mexican Gold Mining Corp.: Mexican Gold Announces Subscription Receipt Financing and Loan to Alcon Silver in Connection with Arrangement
Vancouver, British Columbia--(Newsfile Corp. - June 15, 2026) - Mexican Gold Mining Corp. (TSXV: MEX) ("Mexican Gold" or the "Company") and Alcon Silver Corp. ("Alcon") announce that, in connectio...
Mexican Gold Announces Subscription Receipt Financing and Loan to Alcon Silver in Connection with Arrangement
Vancouver, British Columbia--(Newsfile Corp. - June 15, 2026) - Mexican Gold Mining Corp. (TSXV: MEX) ("Mexican Gold" or the "Company") and Alcon Silver Corp. ("Alcon") announce that, in connection wi...
Alcon price target lowered to CHF 82 from CHF 90 at Citi
Citi lowered the firm’s price target on Alcon (ALC) to CHF 82 from CHF 90 and keeps a Buy rating on the shares.
Is It Too Late to Buy Alcon Inc (ALC) After 3.7% Rally? GF Value Says Undervalued
Is It Too Late to Buy Alcon Inc (ALC) After 3.7% Rally? GF Value Says Undervalued
Alcon management to meet with KeyBanc
Meeting to be held in Boston on June 10 hosted by KeyBanc.
Alcon Inc (ALC) Stock Up 3.7% and Still Undervalued -- GF Score: 78/100
Alcon Inc (ALC) Stock Up 3.7% and Still Undervalued -- GF Score: 78/100
Alcon price target lowered to CHF 70 from CHF 77 at Deutsche Bank
Deutsche Bank analyst Falko Friedrichs lowered the firm’s price target on Alcon (ALC) to CHF 70 from CHF 77 and keeps a Buy rating on the shares. Published first on…
Alcon price target lowered to $78 from $90 at Barclays
Barclays lowered the firm’s price target on Alcon (ALC) to $78 from $90 and keeps an Equal Weight rating on the shares.
Alcon price target lowered to $90 from $98 at Baird
Baird lowered the firm’s price target on Alcon (ALC) to $90 from $98 and keeps an Outperform rating on the shares. The firm updated its model following results where it